Difference Between Interval and Continous Intradialytic Exercise on Functional Capacity in Hemodialysis Patient
NCT ID: NCT05722496
Last Updated: 2023-09-26
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
60 participants
INTERVENTIONAL
2023-01-03
2023-09-10
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Does interval versus continous intradialytic training have an effect on muscle quality index and functional capacity in hemodialysis patients? Patients will be assigned randomly by computerized block randomization into two groups:Group (A): 30 patients will participate in 8 weeks of aerobic exercise in the form of high intensity interval training (HIIT) intradialytic pedaling exercise plus hemodialysis (3 sessions per week).Group (B): 30 patients will participate in 8 weeks of aerobic exercise in the form of moderate intensity continous training (MICT) intradialytic pedaling exercise plus hemodialysis (3 sessions per week) . primary and secondary variables will be measured before starting treatment and after completion (after 2 months )
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effect of Intradialytic Continuous Versus Interval Aerobic Exercises on Functional Capacity in Patients With Chronic Renal Failure.
NCT06173141
Aerobic Versus Resistive Intradialytic Training Effect on Atherogeinc Index in Hemodialysis Patients
NCT07045064
Effect of Exercises on Hemodialysis
NCT07319468
Effect of Autogenic Training on Hemodialysis Patients
NCT07276828
Stretching Exercises for Dialysis Patients to Reduce Muscle Cramps
NCT07262879
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Study include sixty male patients on hemodialysis for 1-3 years aged from 45 to 55 years old selected from hemodialysis unit at National Institute of Urology and Nephrology. Before starting treatment , patients will fill consent form and the study aims and procedure will be explained to each patient . study include Sixty male patients on hemodialysis for 1-3 years aged from 45 to 55 years old selected from hemodialysis unit at National Institute of Urology and Nephrology. Patients will be assigned randomly by computerized block randomization into two groups:Group (A): 30 patients will participate in 8 weeks of aerobic exercise in the form of high intensity interval training (HIIT) intradialytic pedaling exercise plus hemodialysis (3 sessions per week).Group (B): 30 patients will participate in 8 weeks of aerobic exercise in the form of moderate intensity continous training (MICT) intradialytic pedaling exercise plus hemodialysis (3 sessions per week) Karvonen formula will be used to calculate training heart rate THR= RHR+ (HRmax - RHR) 65%-80% AS HRmax = 220-Age patients of HIIT will perform aerobic exercise in the form of leg pedaling exercise in semi-supine position using leg ergometer at high intensity 85%-95% of HRpeak with 4 min of active breaks at an intensity of 60%-70% of HRpeak. . Exercise will be done at the first 2 hours of dialysis (to avoid dialysis hypotension episodes).
patients of MICT will perform aerobic exercise in the form of leg pedaling exercise in semi-supine position using leg ergometer at moderate intensity 50%-60% of HRpeak . Exercise will be done at the first 2 hours of dialysis (to avoid dialysis hypotension episodes).
primary and secondary variables will be measured before starting treatment and after completion (after 2 months )
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
Group (B): 30 patients aged between 45- 55 years old will participate in 8 weeks of aerobic exercise in the form of moderate intensity continous training (MICT) intradialytic pedaling exercise plus hemodialysis (3 sessions per week).
TREATMENT
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
High Intensity Interval Training Group (Group A)
Each training session consist of three parts of 30 minutes:
* Warm up (5 minutes) free active exercise of the lower extremities,
* Training continued with three exercise intervals lasting 3 min each, at an exercise intensity of 85%-95% of HRpeak equalling 15-17 on the Borg scale. Each interval was separated by 4 min of active breaks at an intensity of 60%-70% of HRpeak.
* Cool down (5 minutes) free exercise of lower extremities. Training program will last for 8 weeks with frequency 3times / week.
Aerobic pedaling exercise
aerobic exercise in the form of leg pedaling exercise in semi-supine position using leg ergometer by different intensities
Moderate intensity continous training group (Group B)
Each training session consist of three parts of 30 minutes:
* Warm up (5 minutes) free active exercise of the lower extremities,
* Training continued with cycling at low-to-moderate exercise intensity of 50%-60% of HRpeak, representing 11-13 on the Borg scale.
* Cool down (5 minutes) free exercise of lower extremities. Training program will last for 8 weeks with frequency 3times / week.
Aerobic pedaling exercise
aerobic exercise in the form of leg pedaling exercise in semi-supine position using leg ergometer by different intensities
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Aerobic pedaling exercise
aerobic exercise in the form of leg pedaling exercise in semi-supine position using leg ergometer by different intensities
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Male sex included.
3. Patients with grade 5 chronic renal failure on hemodialysis.
4. Patients are on hemodialysis for 1-3 years.
5. Body mass index (BMI) range from 25-34.9 Kg/m2.
6. They will be medically and psychologically stable.
7. Receiving their physician-prescribed pharmacotherapy regularly.
8. Agree to participate by signing an informed consent form.
Exclusion Criteria
2. Patients with unstable angina, uncontrolled cardiac arrhythmia, decompensated heart failure, persistent systolic blood pressure (BP) greater than 200 mmHg, persistent diastolic BP greater than 120 mmHg, acute pericarditis or myocarditis.
3. Acute systemic infection.
4. Presence of malignant disease.
5. Patients with Diabetes Mellitus.
6. Patients with Lupus Nephritis.
7. Patients with chronic obstructive lung disease, restrictive lung disease or chronic chest infection.
8. Severe obesity (BMI \> 35).
9. Chronic inflammatory orthopedic disorders and rheumatoid arthritis.
10. Patients with muscle injuries or neuromuscular disorders (muscular dystrophy, myasthenia gravis, myopathy, multiple sclerosis and peripheral neuropathy).
45 Years
55 Years
MALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Cairo University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Hadeer Saber Mansour El-Sayed
assistant lecturer at department of cardiovascular, respiratory and geriatrics
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
hala m ezz eldeen, professor
Role: STUDY_DIRECTOR
department of cardiovascular, respiratory and geriatrics disorders
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Faculty of physical therapy, cairo university
Cairo, Dokki, Egypt
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
111118
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.